Weber David M 4
4 · ABIOMED INC · Filed May 18, 2021
Insider Transaction Report
Form 4
ABIOMED INCABMD
Weber David M
Chief Operating Officer
Transactions
- Tax Payment
Common Stock, $.01 par value
2021-05-16$268.56/sh−355$95,339→ 124,577 total - Tax Payment
Common Stock, $.01 par value
2021-05-16$268.56/sh−927$248,955→ 123,650 total
Holdings
- 8,000
Stock Option (right to buy)
Exercise: $134.51From: 2018-05-15Exp: 2027-05-15→ Common Stock (0 underlying) - 6,000
Stock Option (Right to Buy)
Exercise: $266.39From: 2020-05-30Exp: 2029-05-30→ Common Stock (0 underlying) - 10,825
Stock Option (Right to Buy)
Exercise: $21.55From: 2015-05-14Exp: 2024-05-14→ Common Stock (0 underlying) - 15,497(indirect: By Trust)
Common Stock, $.01 par value
- 7,000
Stock Option (right to buy)
Exercise: $99.62From: 2017-05-24Exp: 2026-05-24→ Common Stock (0 underlying) - 6,500
Stock Option (right to buy)
Exercise: $381.97From: 2019-05-16Exp: 2028-05-16→ Common Stock (0 underlying) - 5,000
Stock Option (Right to Buy)
Exercise: $223.90From: 2021-05-29Exp: 2030-05-29→ Common Stock (0 underlying) - 10,000
Stock Option (right to buy)
Exercise: $66.25From: 2016-05-13Exp: 2025-05-13→ Common Stock (0 underlying)
Footnotes (4)
- [F1]Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- [F2]These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
- [F3]Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
- [F4]Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards.